Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × zilucoplan × 90 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Specimen Handling 245 pembrolizumab 242 Magnetic Resonance Spectroscopy 233 Cyclophosphamide 203 Radiotherapy 182 Nivolumab 148 Biopsy 138 Carboplatin 123 Cisplatin 116 venetoclax 115 fludarabine 111 Standard of Care 106 Dexamethasone 104 Radiosurgery 103 Surveys and Questionnaires 99 Paclitaxel 94 Blood Specimen Collection 94 Drug Therapy 91 Gemcitabine 83 Radiation 77 Bevacizumab 76 Oxaliplatin 75 Rituximab 74 Ipilimumab 72 Fluorouracil 68 durvalumab 67 Temozolomide 64 Cytarabine 64 Interviews as Topic 63 Doxorubicin 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Ohio State University

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡